MedPath

Kabimidine

Brand Name: Kabimidine

Generic Name: Dexmedetomidine (as Hydrochloride)

Active
Registration Number

DR-XY47664

Dosage Form

Sterile Solution for I.V. Injection

Issuance Date

July 31, 2024

Expiry Date

January 11, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mcg/mL (200 mcg/ 2 mL)
PackagingUSP Type I clear glass vial with grey rubber stopper, aluminum seal and pink polypropylene flip-off cap x 2 mL (Box of 5's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Hypnotic/ Sedative
A
Application
Initial (Reconstruction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dexmedetomidine (as Hydrochloride)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform